与HPV整合引起的炎症反应相关的遗传突变在口腔状细胞癌中的HPV整合
Mai Atique1,2, Isis Muniz1,2,3, Fatemeh Farshadi1,2
1Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada.
Biomedicines
|January 26, 2024
概括
人类乳头瘤病毒 (HPV) 感染与头癌 (HNC) 有关. 这项研究发现,中性粒细胞透可能是与HPV相关的口腔癌 (OPC) 的预后因素,这表明了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 头癌 (HNC) 是一个重要的全球健康问题.
- 人类乳头瘤病毒 (HPV) 是一个越来越公认的危险因素,特别是在口腔癌 (OPC).
- 了解与HPV相关的OPC分子机制对于改善患者的治疗结果至关重要.
研究的目的:
- 为了研究与HPV相关的OPC的突变特征.
- 分析这些突变对患者结果的影响.
- 确定与HPV相关的OPC的潜在预后因素和治疗点.
主要方法:
- 审查与HPV相关的OPC的文章和存储库的分析.
- 从38个数据集 (8311名患者,12个国家) 收集和分析数据.
- 330个基因的识别和丰富分析,包括对生物过程的等级集群分析.
主要成果:
- 确定了330个与HPV相关的OPC相关的基因,富含炎症反应调节的基因.
- 确定了关键的生物过程,包括调节质细胞细胞因子生产,中性粒细胞激活/降粒,白细胞激活.
- 研究结果表明,中性粒细胞在与HPV相关的OPC的发展和进展中可能发挥作用.
结论:
- 中性粒细胞透和HPV状态是OPC的潜在预后因素.
- 感染HPV的HNC细胞可能会减少中性粒细胞的透,这表明免疫抑制活性.
- 针对HPV介导的中性粒细胞免疫抑制可以增强抗瘤免疫反应并改善HNC患者的存活率.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K


